Document Detail


Management of Gilles de la Tourette syndrome using sulpiride.
MedLine Citation:
PMID:  2357704     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
One hundred and fourteen patients with Gilles de la Tourette syndrome have been reviewed. Sixty-three were managed using sulpiride, and worthwhile beneficial effects occurred in 59%. Our experience with sulpiride compared to other drug treatments is discussed. The main adverse side effects of sulpiride treatment were sustained drowsiness and, possibly, depression. Tardive dyskinesia was not reported in our cohort.
Authors:
M M Robertson; V Schnieden; A J Lees
Related Documents :
22085994 - A novel homozygous 5bp deletion in fkbp10 causes clinically bruck syndrome in an indone...
22179914 - Thoracic outlet syndrome.
22250004 - Investigating the stability of neuropsychiatric sub-syndromes with progression of demen...
11568414 - Decreased volume of the cerebral ventricles on ct images in gilles de la tourette's syn...
18577054 - Ilven-like persistent psoriasiform dermatitis confined to a congenital becker nevus.
16442164 - Cardiolipin metabolism and barth syndrome.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Clinical neuropharmacology     Volume:  13     ISSN:  0362-5664     ISO Abbreviation:  Clin Neuropharmacol     Publication Date:  1990 Jun 
Date Detail:
Created Date:  1990-07-27     Completed Date:  1990-07-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7607910     Medline TA:  Clin Neuropharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  229-35     Citation Subset:  IM    
Affiliation:
National Hospital, Queen Square, London, England.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Child
Female
Humans
Male
Middle Aged
Retrospective Studies
Sleep Stages / drug effects
Sulpiride / adverse effects,  therapeutic use*
Tourette Syndrome / drug therapy*
Chemical
Reg. No./Substance:
15676-16-1/Sulpiride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trisomy 4 in a case of acute biphenotypic leukemia.
Next Document:  Effects of atropine on learning and memory functions in dementia.